Erasca, Inc.
ERAS • NASDAQ
Erasca, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jonathan E. Lim, with a market cap of $4.7B.
CEOJonathan E. Lim
Next Earnings
Upcoming earnings announcement for Erasca, Inc.
Date
Tuesday, May 12, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.22
Earnings History
Past 12 earnings reports for Erasca, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 12, 2026 | Q4 2025 | -$0.10Est: -$0.11 | +9.1% | - | — |  10-K |
| Nov 12, 2025 | Q3 2025 | -$0.11Est: -$0.11 | 0.0% | - | — | 10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.12Est: -$0.12 | 0.0% | - | — | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.11Est: -$0.14 | +21.4% | - | — | 10-Q |
| Mar 20, 2025 | Q4 2024 | -$0.11Est: -$0.13 | +15.4% | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.11Est: -$0.18 | +38.9% | - | — | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$0.29Est: -$0.18 | -61.1% | - | — | 10-Q |
| May 8, 2024 | Q1 2024 | -$0.23Est: -$0.22 | -4.5% | - | — | 10-Q |
| Mar 27, 2024 | Q4 2023 | -$0.20Est: -$0.23 | +13.0% | - | — | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.20Est: -$0.23 | +13.0% | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$0.21Est: -$0.24 | +12.5% | - | — | 10-Q |
| May 15, 2023 | Q1 2023 | -$0.22Est: -$0.31 | +29.0% | - | — | — |